Chimerix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Chimerix and buy or sell other stocks, ETFs, and their options commission-free!About CMRX
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox.
CEOMichael T. Andriole, MBA
CEOMichael T. Andriole, MBA
Employees81
Employees81
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded2000
Founded2000
Employees81
Employees81
CMRX Key Statistics
Market cap787.47M
Market cap787.47M
Price-Earnings ratio-8.67
Price-Earnings ratio-8.67
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.55
52 Week high$8.55
52 Week low$0.75
52 Week low$0.75
Stock Snapshot
With a market cap of 787.47M, Chimerix(CMRX) trades at $8.54. The stock has a price-to-earnings ratio of -8.67.
Chimerix(CMRX) stock opened on 2025-12-14 at —. The price climbed to — and dipped to —.
Chimerix(CMRX) shares are trading with a volume of 0.
In the last year, Chimerix(CMRX) shares hit a 52-week high of $8.55 and a 52-week low of $0.75.
In the last year, Chimerix(CMRX) shares hit a 52-week high of $8.55 and a 52-week low of $0.75.
People also own
Based on the portfolios of people who own CMRX. This list is generated using Robinhood data, and it’s not a recommendation.